Latest Breaking News On - Philippe dubuc - Page 3 : comparemela.com

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance

Theratechnologies Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2023 and Provides 2024 Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesPhilippe dubucJohn leasureChristian marsolaisJulie schneidermanWhile the companyCompany investor relationsCommunications corporate affairsTheratechnologies incInternational tollCompany loan facilityPositive adjustedNet lossChief executiveComplete response letterQuarter fiscal

Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action

Theratechnologies Announces Publication in Frontiers in Immunology that Deepens Understanding of Sudocetaxel Zendusortide (TH1902) Molecular Mechanism of Action
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Philippe dubucJulie schneidermanChristian marsolaisBorhane annabiChemistry departmentTheratechnologies incCommunications corporate affairsSenior vice presidentChief medical officerCancer preventionSudocetaxel zendusortideFast trackForward looking statementsLooking statementsAnnual information formVice president

Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer

Theratechnologies Completes Enrollment of First Six Patients in Updated Phase 1 Clinical Trial of Sudocetaxel Zendusortide in Advanced Ovarian Cancer
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesChristian marsolaisPhilippe dubucJulie schneidermanSudocetaxel zendusortideIra winerKarmanos cancer centerCommunications corporate affairsTheratechnologies incAmerican society of clinical oncologyDrug administrationCompletes enrollmentFirst six patientsUpdated phaseAdvanced ovarianSenior vice president

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

MONTREAL, Feb. 06, 2024 Theratechnologies Inc. , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced the Company will report.

John leasurePhilippe dubucChristian marsolaisDrug administrationTheratechnologies incCompany investor relationsInternational tollGlobenewswire incComplete response letterBiologics license applicationChief executiveSenior vice presidentChief financial officerChief medical officerGlobal commercial officerInvestor relations

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

Theratechnologies to Announce Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

John leasurePhilippe dubucChristian marsolaisInternational tollCompany investor relationsChief executiveSenior vice presidentFinancial officerChief medical officerGlobal commercial officerInvestor relationsVice presidentChief financial